HKD21.85
0.46% day before yesterday
Hong Kong, Dec 27, 09:08 am CET
ISIN
CNE100000FN7
Symbol
1099
Index
Sector
Industry

Sinopharm Group Stock price

HKD21.85
+1.10 5.30% 1M
+1.30 6.33% 6M
+1.40 6.85% YTD
+2.37 12.17% 1Y
+5.19 31.15% 3Y
-6.50 22.93% 5Y
-5.70 20.69% 10Y
Hong Kong, Closing price Fri, Dec 27 2024
-0.10 0.46%
ISIN
CNE100000FN7
Symbol
1099
Index
Sector
Industry

Key metrics

Market capitalization HKD68.19b
Enterprise Value HKD206.23b
P/E (TTM) P/E ratio 7.28
EV/FCF (TTM) EV/FCF 12.06
EV/Sales (TTM) EV/Sales 0.32
P/S ratio (TTM) P/S ratio 0.11
P/B ratio (TTM) P/B ratio 0.84
Dividend yield 4.38%
Last dividend (FY23) HKD0.96
Revenue growth (TTM) Revenue growth -4.17%
Revenue (TTM) Revenue HKD638.74b
EBIT (operating result TTM) EBIT HKD22.03b
Free Cash Flow (TTM) Free Cash Flow HKD17.10b
EPS (TTM) EPS HKD3.00
P/E forward 7.50
P/S forward 0.11
EV/Sales forward 0.32
Show more

Is Sinopharm Group a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

Sinopharm Group Stock Analysis

Unlock Scores for Free

Analyst Opinions

16 Analysts have issued a Sinopharm Group forecast:

11x Buy
69%
4x Hold
25%
1x Sell
6%

Analyst Opinions

16 Analysts have issued a Sinopharm Group forecast:

Buy
69%
Hold
25%
Sell
6%

Financial data from Sinopharm Group

Income Statement P&L | Balance Sheet | Cash Flow


TTM Annually
Jun '24
+/-
%
638,741 638,741
4% 4%
100%
- Direct Costs 588,097 588,097
4% 4%
92%
50,644 50,644
8% 8%
8%
- Selling and Administrative Expenses 23,576 23,576
6% 6%
4%
- Research and Development Expense - -
-
-
27,069 27,069
9% 9%
4%
- Depreciation and Amortization 5,037 5,037
5% 5%
1%
EBIT (Operating Income) EBIT 22,031 22,031
12% 12%
3%
Net Profit 9,361 9,361
7% 7%
1%

In millions HKD.

Don't miss a Thing! We will send you all news about Sinopharm Group directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Sinopharm Group Co., Ltd. is a distributor of pharmaceutical and healthcare products and a value added supply chain service provider in the People's Republic of China. It operates through the following business segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment provides distribution, logistics and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers and other suppliers. The Medical Devices segment consists of the distribution of medical devices in China. The Retail Pharmacy segment refers to the network of retail drug stores in major cities of China via direct operations and franchises. The Other Business segment comprises of the production and sale of pharmaceutical products, chemical reagents and laboratory supplies. The company was founded on January 8, 2003 and is headquartered in Shanghai, China.

Head office China
Employees 115,959
Founded 2003
Website ir.sinopharmgroup.com.cn

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today